ACOR Acorda TherapeuticsWatchlist
About Acorda Therapeutics Company
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine), and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa, and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in New York, NY.
Overview Of Value Stocks In The Healthcare Sector
The Meaning Behind Value StocksA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base i
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersNanoVibronix (NASDAQ:NAOV) stock increased by 71.0% to $2.48 during Wednesday's pre-market session. The company's market cap stands at $4.1 million. Aravive (NASDAQ:ARAV) stock moved upwards by
Acorda Therapeutics (ACOR): A Comprehensive Analysis of Its Market Value
We're seeking community insights on the potential movement of this stock in the coming one to two months. Do you anticipate it to rise or fall?
If you have any solid ideas, insider information, or news that might influence this stock's direction, kindly share in the comments section below. Your input is greatly valued!
Thank you for your participation.
$Grove Collaborative(GROV.US)$ 16m float / 74% institutional/ 30% CTB
$Acorda Therapeutics(ACOR.US)$ 1.2m float/ 18% institutional/ 37% CTB
$Verastem(VSTM.US)$ 16m float / 40% institutional/ 18% CTB
$Cibus Inc(CBUS.US)$ 16m float / 12% institutional
$Bone Biologics(BBLG.US)$ 27m float / 17% institutional/ 127% CTB
$Greenlane(GNLN.US)$ 1.5m float/ 17% institutional/ 35% CTB
$VistaGen Therapeutics(VTGN.US)$ 7.2m floa...